Regenus logo
  • About Regeneus
    • About Regeneus
    • Leadership & Board
    • News & Insights
  • The Science
    • The Science
    • IP and Manufacturing
  • Our Technologies
    • Our Technologies
    • Progenza™
    • Sygenus
  • Pipeline
  • Investor Hub
    • Investor Hub
    • Corporate Governance
    • ASX Announcements
    • Investor Presentations
    • Analyst Coverage
    • Financial Reports
  • Contact
    • Contact Us
    • Clinical Trials
    • Partnership Opportunities
  • Search

News & Insights

AUSTRALIA'S REGENEUS COMMENCES DEVELOPMENT OF MANUFACTURING PROCESS FOR THEIR OA CELLULAR THERAPY

Regeneus Commences Development of Manufacturing Process For Their OA Cellular Therapy. (Japan Chemical Daily Article, May 10, 2017)

by Regeneus Ltd.

Recent Posts

  • Regeneus receives milestone payment from Kyocera
  • Regeneus inks agreement with high profile Japanese life sciences group
  • Regeneus (ASX:RGS) signs MOU with Kyocera for Progenza
  • ASX:RGS – Regeneus AGC Agreement termination paves way for commercial partner
  • ASX:RGS – Regeneus AGC Agreement termination paves way for commercial partner

Categories

  • News
Regenus logo
Sydney Head Office
Regeneus Ltd
2 Paddington Street, Paddington, NSW 2021

Phone: +61 2 9499 8010
Email: info@regeneus.com.au

About
  • About Regeneus
  • Leadership & Board
  • News & Insights
  • Careers at Regeneus
Science
  • The Science
  • IP and Manufacturing
Technology
  • Our Technologies
  • Progenza™
  • Sygenus
Portfolio
  • Product Pipeline
Investors
  • Investor Hub
  • Corporate Governance
  • ASX Announcements
  • Investor Presentations
  • Analyst Coverage
  • Financial Reports
Contact
  • Contact Us
  • Clinical Trials
  • Partnership Opportunities

© Regeneus Ltd. All rights reserved | Privacy Policy | Terms of Service

Privacy Preference Center

Privacy Preferences

Privacy Policy